Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer
2006 · New England Journal of Medicine · 1,405 citations
https://doi.org/10.1056/nejmoa053028
T
Tapio Salminen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
74
Papers
2.5K
Citations
13
h-index
15
i10-index
Tapio Salminen is an academic researcher from Tampere University. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Historical and Archaeological Studies & Genetic factors in colorectal cancer. The author has an h-index of 13, co-authored 63 publications.
ORCID: 0000-0003-4116-2260Papers by this author
worksFluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial
2009 · Journal of Clinical Oncology · 458 citations
https://doi.org/10.1200/jco.2008.21.4577
Performance Comparison of Droplet Digital <scp>PCR</scp> and Next‐Generation Sequencing for Circulating Tumor <scp>DNA</scp> Detection in Non‐Metastatic Rectal Cancer
2025 · Cancer Medicine · 4 citations
https://doi.org/10.1002/cam4.70943
Patient characteristics associated with poor performance status, ECOG 2-3, and effect on survival in 1086 Finnish metastatic colorectal cancers (mCRC) nationwide (prospective RAXO study)
2019 · Annals of Oncology · 2 citations
https://doi.org/10.1093/annonc/mdz246.129
KRAS and NRAS mutations in Nordic population-based and real-world metastatic colorectal cancer cohorts
2025 · BJC Reports · 1 citations
https://doi.org/10.1038/s44276-025-00188-5
An easily adaptable validated risk score predicts cancer-specific survival in stage II colon cancer
2020 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.13079735
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat